Noninvasive Monitoring of Cerebral Blood Flow Autoregulation

Status Completed

Clinical Trial Summary

Rheoencephalography (REG) shows promise as a method for noninvasive neuromonitoring, because it reflects cerebrovascular reactivity. This protocol will study clinical and technical conditions required to use REG. Additionally, our goal is to study noninvasive peripheral bioimpedance pulse waveforms in order to substitute invasive SAP. A previous study demonstrated that REG can be used to detect spreading depolarization (SD), the early sign of brain metabolic disturbance. SD can be measured invasively with DC EEG amplifiers only. Our goal is to create an automatic notification function for REG monitoring indicating change of clinical conditions.

Clinical Trial Description

Neuromonitoring of patients with severe neurological illness are detailed elsewhere. In the setting of cerebral edema, ICP monitoring is a staple of neurocritical care. Pressure AR is an important hemodynamic mechanism that protects the brain against inappropriate fluctuations in CBF in the face of changing CPP. Both static and dynamic AR have been monitored in neurocritical care to aid prognostication and contribute to individualizing optimal CPP targets in patients. Theoretically, failure of cerebral AR is associated with poor outcomes in various acute neurological diseases. Continuous bedside monitoring of autoregulation is now feasible and should be considered as a part of multimodality monitoring including measurement of pressure reactivity. A previous study documented that REG (REGx) and ICP (PRx) has high correlation in order to detect the lower limit of CBF AR. The fundamental relationships between SAP, vessel tone, cerebral blood volume and ICP form the basis for the pressure reactivity index (PRx). PRx is analogous to other time domain AR indices and is calculated as the continuous correlation between thirty consecutive time-averaged (10 s) SAP and ICP values. A positive index (positive correlation) implies impaired passive CBF AR, while a negative index (inverse correlation) implies intact, active AR. The utility and feasibility of REG as a monitoring modality is previously demonstrated and validated as a reflection of cerebrovascular reactivity. The bioimpedance amplifier was used previously at Walter Reed Army Institute of Research (WRAIR) and Naval Medical Research Center (Silver Spring, MD); and has an FDA safety clearance. It is expected that REG can predict evolving vasospasm and expanding intracranial bleeding amongst several other clinical applications. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05170295
Study type	Observational
Source	Ochsner Health System
Contact
Status	Completed
Phase
Start date	April 18, 2018
Completion date	April 28, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03227354` - Validation of Non-invasive Absolute Intracranial Pressure Monitoring	N/A
Completed	`NCT03641443` - non_invasive_aICP_Tumor	N/A
Not yet recruiting	`NCT03828032` - Multi-parameters'Change Process During Dehydration Therapy on Brain Edema Patients.	N/A
Terminated	`NCT03286426` - Ocular Screening in Children and Young Adults at Risk for Increased Intracranial Pressure	N/A
Completed	`NCT03782077` - Change of Optic Nerve Sheath Diameter After Deflation of Pneumatic Tourniquet
Completed	`NCT03195881` - Neuroprognostication Using Optic Nerve Sheath Diameter
Completed	`NCT04446013` - Comparison of ONSD and rSO2 Measurements Between General and Spinal Anesthesia in C-Section	N/A
Completed	`NCT03418753` - Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure
Not yet recruiting	`NCT06288659` - aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial	N/A
Active, not recruiting	`NCT05609071` - Technology of Intracranial Pressure Estimation by Single-Channel EEG in Brain Disease
Completed	`NCT05286697` - The Effect of Optic Nerve Diameter on Postoperative Cognitive Function in Laparoscopic Hysterectomy	N/A
Completed	`NCT06048900` - Evaluation of the Effect of Trendelenburg Position Duration on Intracranial Pressure	N/A
Active, not recruiting	`NCT05731765` - SVP Detection Using Machine Learning
Recruiting	`NCT05346471` - Infra- and Supratentorial Neuromonitoring	N/A
Recruiting	`NCT03344432` - Correlation Intraocular Pressure With Intracranial Pressure	N/A
Recruiting	`NCT05931991` - Intra-operative Evaluation of the External Ventricular Drain Catheter Position With Structured Light for Patients (Bullseye EVD)
Completed	`NCT04004923` - Intracranial Pressure in Monopolar and Bipolar Hysteroscopy	N/A
Recruiting	`NCT04675216` - Posterior Fossa Intracranial Pressure (ICP) Measurement: Clinical Study
Not yet recruiting	`NCT05445271` - Optic Nerve Sheath Diameter in Pediatric Patients	N/A
Completed	`NCT05499754` - Effect of Different Supralottic Airway Devicess on Optic Nerve Sheath Diameter

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.